O. GABRIEL

This study investigated the antidiabetic potential of a bi-herbal aqueous leaf extract in streptozotocin (STZ)-induced diabetic male Wistar rats. Thirty-two rats were divided into six groups: normal control, diabetic untreated control, a group treated with glibenclamide (10mg/kg), and three groups treated with the bi-herbal extract at 50, 100, and 200 mg/kg. Treatments were administered orally for 14 days. Blood glucose levels and lipid profiles were monitored. The results showed that the bi-herbal extract significantly (p < 0.05) reduced blood glucose levels in a manner comparable to glibenclamide. Furthermore, the extract significantly ameliorated diabetes-induced dyslipidemia, as evidenced by reduced levels of total cholesterol, triglycerides, and Low-Density Lipoprotein (LDL) in the treated groups compared to the untreated diabetic control. The study concludes that the bi-herbal extract possesses significant antihyperglycemic and lipid-lowering properties, validating its traditional use in diabetes management.